- Report
- January 2021
- 148 Pages
China, Global
From €3000EUR$3,342USD£2,664GBP
Rifapentine is an antibiotic used to treat tuberculosis (TB). It is a semi-synthetic derivative of rifamycin, a natural antibiotic produced by the bacterium Streptomyces mediterranei. Rifapentine is used in combination with other drugs to treat latent TB infection and active TB disease. It is also used to prevent TB in people who have been exposed to the disease. Rifapentine is generally well tolerated, with few side effects.
Rifapentine is available in both oral and injectable forms. It is typically prescribed as part of a combination therapy, along with other drugs such as isoniazid, pyrazinamide, and ethambutol. The drug is approved for use in adults and children over the age of two months.
The market for rifapentine is growing as the prevalence of TB increases. The World Health Organization estimates that there were 10 million new cases of TB in 2018, and the number is expected to rise in the coming years. As a result, the demand for rifapentine and other TB drugs is expected to increase.
Some companies in the rifapentine market include Sanofi, Mylan, Lupin, and Aurobindo Pharma. Show Less Read more